JP Morgan Chase’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.29B Sell
3,588,484
-3,689,353
-51% -$1.26B 0.07% 238
2026
Q1
$2.54B Buy
7,277,837
+4,984,212
+217% +$1.78B 0.16% 136
2025
Q4
$751M Sell
2,293,625
-1,936,240
-46% -$614M 0.05% 315
2025
Q3
$1.19B Buy
4,229,865
+362,709
+9% +$105M 0.07% 247
2025
Q2
$1.08B Buy
3,867,156
+45,523
+1% +$12.9M 0.07% 249
2025
Q1
$1.19B Buy
3,821,633
+1,294,292
+51% +$382M 0.09% 218
2024
Q4
$659M Buy
2,527,341
+780
+0% +$231K 0.05% 318
2024
Q3
$814M Sell
2,526,561
-78,507
-3% -$25.7M 0.06% 280
2024
Q2
$814M Sell
2,605,068
-1,032,225
-28% -$303M 0.07% 260
2024
Q1
$1.03B Sell
3,637,293
-421,611
-10% -$123M 0.09% 231
2023
Q4
$1.17B Sell
4,058,904
-972,845
-19% -$265M 0.11% 182
2023
Q3
$1.35B Sell
5,031,749
-73,857
-1% -$18.4M 0.15% 141
2023
Q2
$1.13B Sell
5,105,606
-903,164
-15% -$210M 0.12% 179
2023
Q1
$1.45B Sell
6,008,770
-2,166,154
-26% -$532M 0.18% 132
2022
Q4
$2.15B Buy
8,174,924
+2,272,995
+39% +$609M 0.28% 94
2022
Q3
$1.33B Sell
5,901,929
-199,898
-3% -$48.5M 0.19% 123
2022
Q2
$1.48B Buy
6,101,827
+489,547
+9% +$120M 0.21% 109
2022
Q1
$1.36B Buy
5,612,280
+2,017,567
+56% +$464M 0.16% 137
2021
Q4
$809M Buy
3,594,713
+2,039
+0.1% +$430K 0.09% 229
2021
Q3
$764M Sell
3,592,674
-1,756,153
-33% -$404M 0.09% 228
2021
Q2
$1.3B Buy
5,348,827
+236,678
+5% +$58.2M 0.16% 150
2021
Q1
$1.27B Sell
5,112,149
-127,009
-2% -$30.3M 0.17% 145
2020
Q4
$1.2B Sell
5,239,158
-3,031,395
-37% -$699M 0.18% 135
2020
Q3
$2.05B Buy
8,270,553
+1,392,173
+20% +$345M 0.35% 59
2020
Q2
$1.62B Buy
6,878,380
+2,380,375
+53% +$543M 0.31% 64
2020
Q1
$912M Buy
4,498,005
+1,178,068
+35% +$257M 0.21% 103
2019
Q4
$800M Buy
3,319,937
+2,054,336
+162% +$453M 0.15% 147
2019
Q3
$245M Sell
1,265,601
-615,959
-33% -$118M 0.05% 375
2019
Q2
$346M Sell
1,881,560
-480,061
-20% -$86M 0.07% 298
2019
Q1
$449M Sell
2,361,621
-195,624
-8% -$37.4M 0.09% 238
2018
Q4
$498M Buy
2,557,245
+299,057
+13% +$58.3M 0.12% 195
2018
Q3
$468M Buy
2,258,188
+43,879
+2% +$8.65M 0.09% 235
2018
Q2
$409M Sell
2,214,309
-119,120
-5% -$21.1M 0.08% 256
2018
Q1
$398M Sell
2,333,429
-468,765
-17% -$86M 0.09% 252
2017
Q4
$487M Sell
2,802,194
-648,382
-19% -$115M 0.1% 213
2017
Q3
$640M Buy
3,450,576
+717,872
+26% +$127M 0.14% 153
2017
Q2
$471M Buy
2,732,704
+80,597
+3% +$13.1M 0.11% 204
2017
Q1
$435M Sell
2,652,107
-876,872
-25% -$146M 0.1% 222
2016
Q4
$516M Sell
3,528,979
-64,341
-2% -$9.68M 0.12% 184
2016
Q3
$599M Buy
3,593,320
+472,409
+15% +$79.9M 0.15% 160
2016
Q2
$475M Buy
3,120,911
+380,435
+14% +$59.1M 0.12% 197
2016
Q1
$411M Buy
2,740,476
+544,204
+25% +$80.9M 0.11% 219
2015
Q4
$357M Buy
2,196,272
+303,485
+16% +$47.7M 0.09% 254
2015
Q3
$262M Sell
1,892,787
-369,236
-16% -$58.2M 0.07% 289
2015
Q2
$347M Sell
2,262,023
-607,055
-21% -$97.2M 0.08% 269
2015
Q1
$459M Buy
2,869,078
+143,651
+5% +$22.6M 0.1% 216
2014
Q4
$434M Sell
2,725,427
-309,176
-10% -$48.2M 0.1% 227
2014
Q3
$426M Buy
3,034,603
+895,390
+42% +$117M 0.1% 231
2014
Q2
$253M Sell
2,139,213
-853,683
-29% -$98.8M 0.06% 332
2014
Q1
$369M Buy
2,992,896
+493,257
+20% +$59.8M 0.1% 219
2013
Q4
$285M Sell
2,499,639
-1,525,848
-38% -$174M 0.08% 272
2013
Q3
$451M Buy
4,025,487
+780,413
+24% +$84.6M 0.13% 178
2013
Q2
$320M Buy
+3,245,074
New +$337M 0.1% 237

Other funds holding AMGN

JP Morgan Chase's AMGN Position: Q2 2026 in Review

JP Morgan Chase reduced its Amgen (AMGN) stake by 51% in Q2 2026, selling an estimated $1.26B and leaving 3,588,484 shares worth $1.29B. The position accounts for 0.07% of the portfolio, ranked #238.

JP Morgan Chase first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.54B in Q1 2026. 2,563 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • JP Morgan Chase held 3,588,484 shares of Amgen worth $1.29B as of Q2 2026.
  • JP Morgan Chase sold 3,689,353 Amgen shares in Q2 2026, an estimated $1.26B.
  • Amgen made up 0.07% of JP Morgan Chase's portfolio in Q2 2026, its #238 holding.
  • JP Morgan Chase first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • JP Morgan Chase's Amgen position peaked at $2.54B in Q1 2026.
  • 2,563 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.